Kura Oncology, Inc.
Methods of treating cancer patients with farnesyltransferase inhibitors
Last updated:
Abstract:
The present invention relates to the field of molecular biology and cancer biology. Specifically, the present invention relates to methods of treating a subject with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on HRAS mutation status in the subject.
Status:
Grant
Type:
Utility
Filling date:
2 Nov 2017
Issue date:
21 Sep 2021